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Abstract
Objective: To test the safety, feasibility, and effectiveness of reducing sitting time in stroke survivors.
Design: Randomized controlled trial with attention-matched controls and blinded assessments.
Setting: Community.
Participants: Stroke survivors (NZ35; 22 men; mean age, 66.912.7y).
Interventions: Four counseling sessions over 7 weeks with a message of sit less and move more (intervention group) or calcium for bone health
(attention-matched control group).
Main Outcome Measures: Measures included safety (adverse events, increases in pain, spasticity, or fatigue) and feasibility (adherence to trial
protocol). Secondary measures included time spent sitting (including in prolonged bouts 30min), standing, and stepping as measured by the
thigh-worn inclinometer (7d, 24h/d protocol) and time spent in physical activity of at least moderate intensity as measured by a triaxial accel-
erometer. The Multimedia Activity Recall for Children and Adults was used to describe changes in use of time.
Results: Thirty-three participants completed the full protocol. Four participants reported falls during the intervention period with no other adverse
events. From a baseline average of 640.799.6min/d, daily sitting time reduced on average by 3050.6min/d (95% confidence interval [CI], 5.8e
54.6) in the intervention group and 40.492.5min/d in the control group (95% CI, 13.0e93.8). Participants in both groups also reduced their time
spent in prolonged sitting bouts (30min) and increased time spent standing and stepping.
Conclusions: Our protocol was both safe and feasible. Participants in both groups spent less time sitting and more time standing and stepping
postintervention, but outcomes were not superior for intervention participants. Attention matching is desirable in clinical trials and may have
contributed to the positive outcomes for control participants.
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http://dx.doi.org/10.1016/j.apmr.2015.10.094Between 1990 and 2010 worldwide prevalence rates for stroke
increased by 84% (by 27% in high-income countries), making
stroke the third leading cause of disability.1 Up to a third of people
who survive a first stroke will suffer a recurrent stroke within 5
years, with this figure increasing to 43% for people surviving 10
years.2 Both lack of adequate levels of physical activity and high
sedentariness (ie, too much sitting) in this population are likely
contributing factors to recurrent stroke rates. Lack of adequate
physical activity (<150min/wk of moderate-to-vigorous physicalhabilitation Medicine
2 C. English et alactivity [MVPA]) is the second highest population attributable risk
factor for stroke,3 whereas spending long periods of the day sitting
down, particularly in long bouts of uninterrupted sitting, is an
independent risk factor for cardiovascular disease, morbidity, and
mortality in otherwise healthy adults, even after taking into ac-
count the time spent in MVPA.4,5 Studies have shown that people
with stroke are typically both highly sedentary and physically
inactive,6-11 placing them at the greatest risk of the consequences
arising from these conditions. In a recently completed observa-
tional study using high precision activity monitors, people with
stroke were more sedentary and less activity than age-matched
controls, spending 75% of their waking hours sitting down each
day and <5min/d in MVPA.6
Experimental studies12 and epidemiologic studies13 have
shown that breaking up sitting time with periods of light intensity
physical activity (eg, walking at a comfortable pace) leads to re-
ductions in cardiovascular disease risk factors12 and mortality.13
Therefore, interventions aimed at reducing daily sitting time
may be a promising new target for reducing recurrent stroke risk.
However, there are many reasons why people with stroke spend
long periods sitting down, including mobility impairments, post-
stroke fatigue, pain, and spasticity. This means that people with
stroke may find it difficult to sit less each day. Furthermore,
encouraging people with stroke to move more each day may lead
to increased exposure to risk of falls.
The aim of this pilot randomized controlled trial was to assess
the safety, feasibility, and effectiveness of an intervention to
reduce sitting time in people with stroke. Our primary hypotheses
were that the intervention would be both safe (not lead to adverse
events, including falls, negative changes in pain, spasticity, and
fatigue) and feasible (have a high adherence to the measurement
protocol, in particular the activity monitor wear time). Our sec-
ondary hypotheses were that the intervention would lead to a
reduction in sitting time, a reduction in prolonged sitting time
(bouts 30-min duration),14 and an increase in standing and
stepping time and time spent in MVPA. We considered a 30-min/d
reduction in sitting time as the minimal clinically important
difference. In healthy, inactive adults, replacing 1h/d of self-
reported sitting with light-intensity activity has been linked to
lower all-cause mortality.13 As the dose-response relation between
sedentary physical activity and health is nonlinear,13 it is possible
that even smaller reductions in sitting time will have health ben-
efits for people who are both more sedentary (spend more time
sitting) and more inactive (spend less time in MVPA), particularly
when measured accurately and objectively as opposed to
self-report.Methods
This was a pilot randomized controlled trial with an attention-
matched control group, concealed allocation, and blinded assess-
ment of outcome. The trial was registered with the Australian and
New Zealand Trial Registry (ACTRN12612000958886). Partici-
pants were unaware of the intervention of interest. They were told
only that this was a trial of healthy living after stroke. A 1:1List of abbreviations:
CI confidence interval
MARCA Multimedia Activity Recall for Children and Adults
MVPA moderate-to-vigorous physical activityrandomization sequence was prepared by a statistician indepen-
dent of the project. A research assistant independent of the project
prepared a set of sequentially numbered, opaque, sealed envelopes
with the group allocation inside. Participants were recruited from
outpatient clinics, databases of participants from previous trials,
stroke exercise classes, and social media. Research staff repeat-
edly visited outpatient clinics and stroke exercise classes to
identify potential participants. Flyers were also placed in clinics,
and frequent phone calls were made to therapy staff within these
centers to assist in recruitment. A trained assessor who was un-
aware of group allocation assessed participants at baseline (pre-
intervention) and postintervention. Ethical approval was obtained
from the relevant ethics committees, and participants provided
written, informed consent. Because the primary outcomes were
safety and feasibility, we did not power the trial to detect statis-
tically significant changes in sitting time. Changes in sitting time
were interpreted in light of what we considered the minimal
clinically important difference in daily sitting time (30min/d).13
Participants
We recruited people living at home after stroke. Inclusion criteria
were as follows: at least 6 months since last stroke (to minimize
the impact of rapid improvement in functional recovery after
stroke); living at home for at least 3 months since last hospital
discharge; some residual walking and/or balance deficits (self-
reported); and sufficient cognitive and language ability to provide
informed consent and participate in the motivational interview-
ing sessions.
Intervention
Participants were randomly assigned to the intervention or con-
trol group. Participants in the intervention group received a series
of 4 counseling sessions with the main message being to sit less
and move more, with encouragement to regularly break up sitting
time with short bursts of light-intensity activity (standing,
walking at a comfortable pace). Interventions specifically tar-
geted at reducing sitting time have been found to be more
effective than those aimed at general lifestyle advice or advice to
increase MVPA.15 The counseling sessions were provided by 2
researchers (C.E., E.B.), both of whom were formally trained in
motivational interviewing techniques through accredited courses.
Motivational interviewing is a form of goal-directed counseling
that aims to strengthen a person’s own motivation and commit-
ment to change and is particularly effective in eliciting behavior
change for people who are reluctant or ambivalent about
change.16 The first session was provided face-to-face in the
participant’s home. At this first session, participants were pre-
sented with an individualized written report which provided
feedback regarding daily sedentary time and breaks in sedentary
time based on the baseline hip-worn accelerometer data. This
report was used as the starting point for discussions. The coun-
seling sessions used key motivational interviewing techniques
(decisional balance sheets, importance and confidence rulers) to
initiate and reinforce change talk. Action plans, goals, and stra-
tegies were elicited from the participants, rather than imposed by
the counselors. Follow-up counseling sessions were delivered by
phone and occurred 1, 3, and 7 weeks after the initial session. We
chose to deliver the intervention via a face-to-face home visit and
follow-up telephone calls, rather than in groups to avoid transport
being a barrier to participation.17 To match the groups forwww.archives-pmr.org
Reducing sitting time after stroke 3attention, control group participants received the same schedule
of interviews, with a placebo message of increasing calcium for
bone health. Data from a food frequency questionnaire were used
to create personalized feedback for control participants.18 The
food frequency questionnaire was used to reinforce the credi-
bility of the attention-matched control group, and data were
not analyzed.
Outcome measures
Baseline measures were collected at the first face-to-face
appointment and included stroke type (Oxfordshire Stroke Clas-
sification19), stroke severity (National Institutes of Stroke Scale;
score range, 0e42, with higher scores indicating more severe
stroke), side of stroke, height, weight, walking speed (self-
selected, measured over the middle 5 m of a 9-m walkway), use of
walking aids, living arrangements (alone/with spouse), degree of
independence in activities of daily living (self-reported as inde-
pendent or requiring some assistance in daily tasks, such as
showering, dressing, and cooking), and cognitive function (Mon-
treal Cognitive Assessment; score range, 0e30, with scores <22
indicating cognitive dysfunction20). All participants completed a
food frequency questionnaire.18 At this appointment, participants
were fitted with 3 activity monitors and provided with instructions
regarding keeping diaries of sleep/wake time and when monitors
should be removed. Participants wore all 3 monitors for 7 days at
baseline and again 1 week after the final counseling session
(postintervention).
Safety
Safety was assessed by recording changes in self-reported pain
and spasticity (visual analog scale, anchored at 0 [no pain/spas-
ticity] and 10 [severe pain/spasticity]) and fatigue (Checklist In-
dividual Strength; score range, 8e56, with higher scores
indicating greater fatigue symptoms21). Falls incidence and any
other adverse events were ascertained by asking structured ques-
tions (Have you fallen or tripped over in the last 2mo?) at each
assessment point. Although simple recall of falls can underesti-
mate falls incidence, it does not underestimate injurious falls
(specificity, 87%e100%).22
Feasibility
Feasibility was assessed via adherence to counseling sessions
(actively engaged in all scheduled counseling sessions) and
completion of all assessments at baseline and postintervention,
including activity monitor wear time.
Time spent sitting, standing, and stepping
Time spent sitting, standing, and stepping was measured using the
activPAL3 device,a which was waterproofed and attached to the
participants’ anterior thigh on the nonhemiparetic leg. Participants
wore thismonitor continuously (24h/d) for 7 days, including during
showering/bathing and water-based activities. The activPAL3
contains an inclinometer and a triaxial accelerometer. In studies of
both healthy adults and people with stroke, it has been shown to be
99% to 100% accurate in classifying sitting/lying and standing
postures.23,24 The activPAL3 data were processed using activPAL3
software (version 7.2.32).a Sleep/wake diaries were entered into a
Microsoft Access database.b A custom-built SAS program linked
activPAL3 data to the sleep/wake diaries to identify and remove
sleep and nonwear time. This program also identified periods of
prolonged, uninterrupted sitting of 30-minutes duration.www.archives-pmr.orgPhysical activity
Physical activity was measured using the Actigraph GT3þ triaxial
accelerometer,c which was worn on an elastic waist belt and posi-
tioned over the nonhemiparetic hip. Participants were asked towear
the monitor 24h/d for 7 days, removing it for showering/bathing or
any other water-based activities. Participants also wore the Sense-
wear arm bandd around their nonhemiparetic upper arm. In this
trial, the Sensewear arm band was used purely to determine non-
wear time for the Actigraph. Because the Sensewear arm band
switches off when not in contact with the skin and also had to be
removed for water-based activities, we made the assumption
(backed up by review of participant diaries) that the Actigraph and
Sensewear monitors were always removed at the same time.
Actigraph data were processed by ActiLife software (version
6.3.2),c and periods of sleep (matched to activPAL data) and non-
wear (as detected by the Sensewear arm band) were removed using
custom filters. In line with the most commonly used cut points for
classification of activity intensity of older adults,25 activity of at
least moderate intensity was defined as1952 counts per minute.26
Use of time
Use of time was measured using the Multimedia Activity Recall
for Children and Adults (MARCA).27 This computerized use of
time tool asks participants to recall their previous day from
midnight to midnight and classifies activities according to a pre-
determined list of 520 separate items. Activities are then classified
into time spent in various superdomains (eg, transport, screen
time, chores). The superdomains are further categorized into
macrodomains (eg, active and passive transport, computer and
television time). Participants were phoned at a predetermined time
during the week they were wearing the monitors at baseline and
postintervention, and the MARCAwas administered by interview,
which took approximately 20 minutes. In a previous observational
study, agreement between repeated administration of the MARCA
on the same day ranged from .834 (95% confidence interval [CI],
.681e.918) to .946 (95% CI, .890e.974) for the different
MARCA superdomains.6 The MARCA has been validated against
doubly labeled water in young adults, with a correlation of rZ.70
for daily energy expenditure.28Statistical analyses
Paired t tests (or Wilcoxon signed-rank tests where data were not
normally distributed) were used to examine within-group differ-
ences between baseline and postintervention in safety and feasi-
bility measures (pain, spasticity, fatigue, monitor wear time, and
falls). To adjust for waking hours, activPAL3- and Actigraph-
derived activity variables (time spent in sitting, prolonged
sitting, standing, stepping, and MVPA) were standardized to a 16-
h/d waking wear time period. Paired t tests (or Wilcoxon signed-
rank tests where data were not normally distributed) were used to
examine within-group differences between baseline and post-
intervention in activity variables. Univariate analyses of variance
(with adjustment for multiple comparisons) were used to examine
between-group differences in change scores (postintervention
minus baseline) in time spent sitting, standing, stepping, and
MVPA. Independent t tests were used to examine between-group
differences in MARCA-derived variables between the intervention
and control groups. Sequential Bonferroni corrections were
applied to account for multiple comparisons. All analyses were by
intention to treat.
Table 1 Participant characteristics
Characteristic
Whole
Sample
(NZ33)
Intervention
Group
(nZ19)
Control
Group
(nZ14)
Age (y) 66.912.7 65.412.3 67.813.8
Males 22 (62.9) 13 (68.4) 9 (64.3)
First stroke 28 (80.0) 12 (63.2) 14 (100)
Stroke type*
TACI 6 (17.1) 5 (26.3) 1 (7.1)
PACI 13 (37.1) 9 (47.4) 3 (21.4)
LACI 7 (20) 3 (15.8) 4 (28.6)
Hemorrhage 9 (25.7) 2 (10.5) 6 (42.9)
Stroke severity score (NIHSS)
No symptoms (0) 6 (17.1) 3 (15.8) 3 (21.4)
Mild (1e4) 20 (57.1) 11 (57.9) 7 (50.0)
Moderate/severe (>4) 9 (25.7) 5 (26.3) 4 (28.6)
Time since stroke (y) 3.23.4 2.82.6 4.14.3
Living arrangement
Spouse/other 27 (77.1) 14 (73.7) 12 (85.7)
4 C. English et alResults
Participants were recruited between February 2013 and February
2014, with final data collected in May 2014. Figure 1 presents the
flow of participants through the trial. Table 1 presents baseline
characteristics of the 35 participants. Four (intervention: nZ2;
control: nZ2) participants reported falls during the intervention
period. None of the falls were injurious. There were no other
adverse events reported. Pain, spasticity, and fatigue did not
change between baseline and postintervention for either group
(table 2). Compliance with wearing the activity monitors was
high. At baseline, 23 and 31 participants had 7 days of valid data
from the activPAL3 and Actigraph monitors, respectively. All
other participants had at least 4 days of wear time for both
monitors, with the exception of 3 participants for whom the
Actigraph monitor did not record any valid data on any days. At
postintervention, 33 and 25 participants had 7 days of valid data
from the activPAL3 and the Actigraph monitors, respectively. All
other participants had at least 4 valid wear days for both the
activPAL3 and Actigraph monitors, with the following exceptions:Lost to follow-up
n=0
Completed postintervention 
assessment
n=19
Lost to follow-up 
n=2 (health reasons not 
related to the trial)
Completed postintervention 
assessment
n=14
Randomized
n=35
Intervention
n=19
Control
n=16
Received allocated 
intervention
n=16
Received allocated 
intervention
n=19
Analyzed
n=14
Analyzed
n=19
Potential participants 
contacted 
n=72
Fig 1 Consolidated Standards of Reporting Trials statement
flowchart.
Alone 8 (22.9) 5 (26.3) 3 (14.3)
Independence in ADLs
Independent 23 (65.7) 14 (73.7) 7 (50.0)
Requires assistance 12 (34.3) 5 (26.3) 7 (50.0)
Use of walking aid
No aids 23 (65.7) 13 (68.4) 9 (64.3)
Walking stick 10 (28.6) 5 (26.3) 4 (28.6)
Frame 2 (5.7) 1 (5.3) 1 (7.1)
Walking speed (m/s) 0.810.41 0.800.36 0.820.51
BMI (kg/m2) 28.64.8 29.35.8 27.53.0
MoCA score 24.23.6 24.04.2 24.42.7
NOTE. Values are mean  SD or n (%).
Abbreviations: ADL, activities of daily living; BMI, body mass index;
LACI, lacunar infarct circulation infarct; MoCA, Montreal Cognitive
Assessment; NIHSS, National Institutes of Health Stroke Scale; PACI,
partial anterior circulation infarct; TACI, total anterior circulation
infarct.
* Oxfordshire Stroke Classification.2 participants (both in the control group) did not complete the
postintervention assessment for reasons of ill health not related to
the trial, and a further 3 participants did not have any valid wear
days for the Actigraph monitor. Table 2 presents average wear
days and monitored hours for all of the participants. There was
100% compliance with counseling sessions (ie, all participants
engaged in all scheduled counseling sessions).
At baseline, participants spent an average of 640.799.6min/d
sitting, 436.2147min/d in prolonged sitting (uninterrupted sitting
bouts of 30min), 153.663.9min/d standing, 59.336.8min/d
stepping, and 7.48.6min/d inMVPA. Table 3 presents baseline and
follow-up values for the intervention and control groups (unadjusted
for wear time). Table 4 presents data standardized to a 16-hour
waking wear time, including within-group and between-group ef-
fects. Here, daily sitting time reduced on average by 30.050.6min/d
(95% CI, 5.8e54.6) in the intervention group and 40.492.5min/d
(95% CI, 13.0e93.8) in the control group. Prolonged sitting time
reduced on average by 36.165min/d (95% CI, 4.8e67.5) in the
intervention group and 44.2134.2min/d (95% CI, 33.3e121.7) in
the control group. Reductions in sitting time were replaced with in-
creases in time spent standing (intervention: 22.535.5min/d; con-
trol: 33.859min/d) and stepping (intervention: 7.819.2min/d;www.archives-pmr.org
Table 2 Safety and feasibility measures
Outcomes
Intervention Group Control Group
Baseline (nZ19) Postintervention (nZ19) Baseline (nZ14) Postintervention (nZ14)
Pain, VAS (cm) 3.42.8 3.23.1* 3.73.5 3.43.3*
Spasticity, VAS (cm) 3.02.8 2.42.4* 3.63.2 3.82.7*
Fatigue score, CIS 34.19.3 32.38.3y 32.911.7 35.310.7y
No. of fallsz
0 16 (84.2) 11 (78.6)
1 1 (5.3) 1 (7.1)
2 1 (5.3) 1 (7.1)
Missing 1 (5.3) 1 (7.1)
No. of valid wear days activPAL3 6.10.8 6.90.2 5.60.9 6.90.4
Waking wear hoursx activPAL3 (h/d) 14.41.2 14.11.3 14.11.2 14.01.6
No. of valid wear days Actigraph 6.50.9 6.60.8 6.70.6 6.80.6
Waking wear hoursx Actigraph (hr/d) 14.61.1 14.11.4 14.51.5 14.21.4
NOTE. Values are mean  SD or n (%).
Abbreviations: CIS, Checklist Individual Strength; VAS, visual analog scale.
* No significant difference, Wilcoxon signed-rank test.
y Significant difference, paired t test.
z Number of falls reported during the intervention period.
x Waking hours monitored.
Reducing sitting time after stroke 5control: 6.69.9min/d). No differences were statistically significant
after sequential Bonferroni adjustments. On average, both interven-
tion and control group participants exceeded the target of reducing
sitting time by at least 30min/d, with effect sizes of .62 and .46,
respectively. At<10min/d, average time spent in MVPA (Actigraph
data) remained very low for all participants at baseline and post-
intervention. Regarding reported use of time (MARCA data), par-
ticipants reported reductions in sedentary activities, in particular
television viewing (46 and 38min/d for the intervention and
control groups, respectively), but there were no significant between-
group differences in any of the domains (table 5).Discussion
Stroke survivors are both sedentary (spending large proportions of
their day sitting down), and physically inactive. Previous research
has largely focused on encouraging stroke survivors to increase
their time in physical activity of at least moderate intensity. This is
the first clinical trial to investigate an intervention aimed at
encouraging stroke survivors to replace sitting time with light-
intensity activity (ie, sit less and move more). Our protocol was
both safe and feasible, with no adverse events (apart from 4Table 3 Sitting time and physical activity
Outcomes
Interven
Baseline
Total sitting time (min/d) 645.899.9
Sitting time accumulated in bouts 30min (min/d) 431.1155.7
Standing time (min/d) 154.866.8
Stepping time (min/d) 59.640.6
MVPA, 1952 cpm (min/d) 8.210.5
NOTE. Values are mean  SD, not adjusted for wear time.
Abbreviation: cpm, counts per minute.
www.archives-pmr.orgnoninjurious falls: 2 in the control group, and 2 in the intervention
group) and high compliance. On average, participants in both
groups reduced their sitting time by at least 30min/d and replaced
sitting time with standing and stepping. However, there was
considerable intraindividual variability in the magnitude of
change, and participants in the intervention group did not show
superior outcomes relative to the control group.
The trial was not powered to detect statistically significant
intervention effects. However, the attention-matched control group
may have played a role in the lack of between-group differences.
Participants in the control arm of the trial received the same
number of counseling sessions as intervention participants. In an
attempt to further reduce bias, participants were unaware of the
intervention of interest; they were told the trial was about healthy
living after stroke and that they would receive counseling based on
either diet or exercise. Although the content of the counseling
sessions in the control group focused on a dietary message,
anecdotally many participants reported changing physical activity
habits (eg, going for more regular walks, recommencing gym
programs). The activity monitors worn by all participants did not
provide any real-time feedback; however, it is possible that they
could have impacted on activity levels in all participants. Deter-
mining the key active elements in any intervention is important.tion Group (nZ19) Control Group (nZ14)
Postintervention Baseline Postintervention
609.7121.0 633.8102.5 589.9111.5
396.0177.3 443.2139.8 396.4162.6
171.373.9 151.962.1 183.590.8
64.345.0 59.032.4 65.542.3
6.69.5 6.65.9 9.910.4
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6 C. English et alCurrently, the evidence for the effectiveness of behavior
change interventions and self-management programs for
increasing physical activity in people with stroke is limited.29 Very
few high-quality trials have been conducted to date, and there is
little similarity in the content of the interventions delivered.29 We
chose to use a motivational interviewing intervention to target
behavior change in this study. Although 1 previous study found
this approach to be effective in increasing physical activity in
people after stroke,30 more high-quality trials are needed to
evaluate the relative effectiveness of different behavior change
interventions for people with stroke.
The barriers for people with stroke to exercise regularly at a
moderate intensity are often insurmountable,17,31 and efforts to
address this have been largely ineffective.32,33 Reducing daily
sitting time may be a more achievable target with significant
health benefits. We recently modeled the impact of replacing
sitting with standing or stepping time or both, using accelerometer
(activPAL3)-based measures of sitting time in a large sample of
healthy adults.34 Replacing 2h/d of sitting with either standing or
stepping was associated with important reductions in cardiovas-
cular disease risk.34 Furthermore, experimental work in healthy
adults has demonstrated that reductions in sitting time lead to
clinically worthwhile reductions in cardiovascular disease risk
factors (eg, improved glucose metabolism, reduced insulin resis-
tance, decreased blood pressure), at least in the short term.12,35
However, the longer-term benefits of changes in sitting time are
not known.
Study limitations
The lack of difference between intervention and control partic-
ipants suggests the intervention requires development. We did
not formally evaluate the degree to which our intervention
adhered to motivational interviewing principles, or if there were
any differences related to the 2 individual counselors delivering
the intervention. This may also have contributed to the fact that
the intervention expected to change behavior the most was not
more effective. Furthermore, seasonal variations in habitual
physical activity levels have been well documented36 and may
have played a role in this trial because data were collected across
a 15-month time period. Although both modeling of epidemio-
logic data13 and experimental work12 suggest that changes in
sitting time may lead to clinically meaningful reductions in
cardiovascular disease risk, this requires testing in large-scale
clinical trials. The study was not powered to detect a differ-
ence in safety measures between groups; therefore, we cannot
exclude the possibility of modest harms. Future trials should
carefully monitor fall rates and fear of falling. Accelerometers
(eg, Actigraph) tend to underestimate step counts in people with
slow walking speeds.37 This may have affected the accuracy of
the absolute values of physical activity in some of our partici-
pants, but it is not likely to have affected estimations of change
over time. Finally, although all participants self-reported they
had residual walking or balance deficits, 17% of participants
recorded no symptoms on the National Health Institute of Stroke
Severity Scale, indicating minimal to no disability.Conclusions
To our knowledge, this is the first clinical trial to demonstrate that
it is possible for people with stroke to sit less each day. We havewww.archives-pmr.org
Table 5 Use of time data measured by the MARCA
Activity, min/d
Control Group Intervention Group
Difference Between Groups
in Change Scores
Baseline Postintervention Baseline Postintervention
InterventioneControl,
Mean Difference P
Total sitting time 679167 667217 668136 593170 63 .28
Television 221157 183133 303183 257120 8 .13
Passive transport 3641 6258 5064 4249 34 .10
Reading 4561 7569 4778 5192 26 .42
Sit and talk 87109 5851 5062 7292 26 .42
NOTE. Values are mean  SD or as otherwise indicated.
Reducing sitting time after stroke 7demonstrated that the clinical trial protocol is both safe and
feasible and leads to reductions in daily sitting time. However, the
health benefits associated with sitting less each day
remain unclear.Suppliers
a. PAL Technologies.
b. Microsoft Access 2010; Microsoft.
c. Actigraph.
d. Sensewear arm band; Temple Healthcare.Keywords
Exercise; Rehabilitation; Sedentary lifestyle; Stroke; Walking
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